| UniProt ID | WT1_HUMAN | |
|---|---|---|
| UniProt AC | P19544 | |
| Protein Name | Wilms tumor protein | |
| Gene Name | WT1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 449 | |
| Subcellular Localization |
Nucleus . Nucleus, nucleolus. Cytoplasm. Isoforms lacking the KTS motif have a diffuse nuclear location (PubMed:15520190). Shuttles between nucleus and cytoplasm. Isoform 1: Nucleus speckle . Isoform 4: Nucleus, nucleoplasm . |
|
| Protein Description | Transcription factor that plays an important role in cellular development and cell survival. [PubMed: 7862533 Recognizes and binds to the DNA sequence 5'-GCG(T/G)GGGCG-3'] | |
| Protein Sequence | MGSDVRDLNALLPAVPSLGGGGGCALPVSGAAQWAPVLDFAPPGASAYGSLGGPAPPPAPPPPPPPPPHSFIKQEPSWGGAEPHEEQCLSAFTVHFSGQFTGTAGACRYGPFGPPPPSQASSGQARMFPNAPYLPSCLESQPAIRNQGYSTVTFDGTPSYGHTPSHHAAQFPNHSFKHEDPMGQQGSLGEQQYSVPPPVYGCHTPTDSCTGSQALLLRTPYSSDNLYQMTSQLECMTWNQMNLGATLKGVAAGSSSSVKWTEGQSNHSTGYESDNHTTPILCGAQYRIHTHGVFRGIQDVRRVPGVAPTLVRSASETSEKRPFMCAYPGCNKRYFKLSHLQMHSRKHTGEKPYQCDFKDCERRFSRSDQLKRHQRRHTGVKPFQCKTCQRKFSRSDHLKTHTRTHTGKTSEKPFSCRWPSCQKKFARSDELVRHHNMHQRNMTKLQLAL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 54 (in isoform 8) | Phosphorylation | - | 39.53 | - | |
| 54 (in isoform 7) | Phosphorylation | - | 39.53 | - | |
| 62 | Phosphorylation | APPPAPPPPPPPPPH CCCCCCCCCCCCCCC | 53.63 | 27251275 | |
| 67 (in isoform 8) | Phosphorylation | - | 45.04 | 27251275 | |
| 67 (in isoform 7) | Phosphorylation | - | 45.04 | 27251275 | |
| 69 (in isoform 8) | Phosphorylation | - | 40.91 | 25262027 | |
| 69 (in isoform 7) | Phosphorylation | - | 40.91 | 25262027 | |
| 70 | Phosphorylation | PPPPPPHSFIKQEPS CCCCCCCCCCCCCCC | 34.15 | 24719451 | |
| 71 | Phosphorylation | PPPPPHSFIKQEPSW CCCCCCCCCCCCCCC | 8.01 | 24719451 | |
| 73 | Sumoylation | PPPHSFIKQEPSWGG CCCCCCCCCCCCCCC | 46.74 | 15520190 | |
| 73 | Sumoylation | PPPHSFIKQEPSWGG CCCCCCCCCCCCCCC | 46.74 | - | |
| 76 (in isoform 8) | Phosphorylation | - | 32.65 | 24719451 | |
| 76 (in isoform 7) | Phosphorylation | - | 32.65 | 24719451 | |
| 107 (in isoform 9) | Phosphorylation | - | 3.17 | 27732954 | |
| 108 (in isoform 9) | Phosphorylation | - | 38.62 | 23684312 | |
| 110 (in isoform 9) | Phosphorylation | - | 7.54 | 26434776 | |
| 112 (in isoform 9) | Phosphorylation | - | 23.26 | 23684312 | |
| 116 (in isoform 9) | Phosphorylation | - | 44.29 | 26434776 | |
| 117 (in isoform 9) | Phosphorylation | - | 44.86 | 26434776 | |
| 125 (in isoform 9) | Phosphorylation | - | 14.39 | 27732954 | |
| 141 | Sumoylation | LPSCLESQPAIRNQG CHHHHHCCCCHHCCC | 23.28 | - | |
| 177 | Sumoylation | QFPNHSFKHEDPMGQ CCCCCCCCCCCCCCC | 49.45 | - | |
| 177 | Sumoylation | QFPNHSFKHEDPMGQ CCCCCCCCCCCCCCC | 49.45 | 15520190 | |
| 245 | Sumoylation | WNQMNLGATLKGVAA CCCCCCCCEEEEECC | 16.96 | - | |
| 251 (in isoform 3) | Phosphorylation | - | 18.12 | 27732954 | |
| 251 (in isoform 2) | Phosphorylation | - | 18.12 | 27732954 | |
| 252 (in isoform 3) | Phosphorylation | - | 18.92 | 23684312 | |
| 252 (in isoform 2) | Phosphorylation | - | 18.92 | 23684312 | |
| 254 (in isoform 3) | Phosphorylation | - | 23.48 | 26434776 | |
| 254 (in isoform 2) | Phosphorylation | - | 23.48 | 26434776 | |
| 256 (in isoform 3) | Phosphorylation | - | 40.63 | 23684312 | |
| 256 (in isoform 2) | Phosphorylation | - | 40.63 | 23684312 | |
| 260 (in isoform 3) | Phosphorylation | - | 9.49 | 26434776 | |
| 260 (in isoform 2) | Phosphorylation | - | 9.49 | 26434776 | |
| 260 (in isoform 6) | Phosphorylation | - | 9.49 | - | |
| 261 (in isoform 2) | Phosphorylation | - | 25.23 | 26434776 | |
| 261 (in isoform 3) | Phosphorylation | - | 25.23 | 26434776 | |
| 261 | Phosphorylation | SSSSVKWTEGQSNHS CCCCCEECCCCCCCC | 25.23 | 22115753 | |
| 262 (in isoform 6) | Phosphorylation | - | 54.87 | - | |
| 265 | Phosphorylation | VKWTEGQSNHSTGYE CEECCCCCCCCCCCC | 47.57 | 24247654 | |
| 268 | Phosphorylation | TEGQSNHSTGYESDN CCCCCCCCCCCCCCC | 27.98 | 22115753 | |
| 269 | Phosphorylation | EGQSNHSTGYESDNH CCCCCCCCCCCCCCC | 35.91 | 28348404 | |
| 269 (in isoform 3) | Phosphorylation | - | 35.91 | 27732954 | |
| 269 (in isoform 2) | Phosphorylation | - | 35.91 | 27732954 | |
| 271 | Phosphorylation | QSNHSTGYESDNHTT CCCCCCCCCCCCCCC | 16.61 | 22115753 | |
| 273 | Phosphorylation | NHSTGYESDNHTTPI CCCCCCCCCCCCCCE | 34.92 | 24247654 | |
| 277 | Phosphorylation | GYESDNHTTPILCGA CCCCCCCCCCEEECE | 40.29 | 22115753 | |
| 278 | Phosphorylation | YESDNHTTPILCGAQ CCCCCCCCCEEECEE | 10.77 | 22115753 | |
| 295 | Methylation | IHTHGVFRGIQDVRR EECCCHHCCHHHHHC | 38.61 | 115920097 | |
| 309 | Phosphorylation | RVPGVAPTLVRSASE CCCCCCCHHHHCCCC | 28.31 | 25072903 | |
| 313 | Phosphorylation | VAPTLVRSASETSEK CCCHHHHCCCCCCCC | 28.77 | 25072903 | |
| 315 | Phosphorylation | PTLVRSASETSEKRP CHHHHCCCCCCCCCC | 42.53 | 25072903 | |
| 317 | Phosphorylation | LVRSASETSEKRPFM HHHCCCCCCCCCCCC | 39.42 | 25072903 | |
| 318 | Phosphorylation | VRSASETSEKRPFMC HHCCCCCCCCCCCCC | 36.75 | 25072903 | |
| 324 (in isoform 8) | Phosphorylation | - | 1.10 | 27732954 | |
| 325 (in isoform 8) | Phosphorylation | - | 3.16 | 23684312 | |
| 327 (in isoform 8) | Phosphorylation | - | 8.67 | 26434776 | |
| 329 (in isoform 8) | Phosphorylation | - | 18.23 | 23684312 | |
| 333 (in isoform 8) | Phosphorylation | - | 28.29 | 26434776 | |
| 334 (in isoform 8) | Phosphorylation | - | 13.48 | 26434776 | |
| 341 | Phosphorylation | YFKLSHLQMHSRKHT HEEHHHHHHCCCCCC | 23.32 | 24719451 | |
| 342 (in isoform 8) | Phosphorylation | - | 3.79 | 27732954 | |
| 348 | Phosphorylation | QMHSRKHTGEKPYQC HHCCCCCCCCCCCCC | 50.50 | 23532336 | |
| 363 | Methylation | DFKDCERRFSRSDQL CHHHHHHHCCCHHHH | 16.17 | - | |
| 365 | Phosphorylation | KDCERRFSRSDQLKR HHHHHHCCCHHHHHH | 29.12 | 11237525 | |
| 386 | Phosphorylation | GVKPFQCKTCQRKFS CCCCCCCCHHCCCCC | 41.37 | 24719451 | |
| 387 (in isoform 2) | Phosphorylation | - | 22.84 | - | |
| 389 (in isoform 2) | Phosphorylation | - | 57.75 | - | |
| 393 | Phosphorylation | KTCQRKFSRSDHLKT CHHCCCCCCCHHHCE | 33.63 | 11237525 | |
| 404 (in isoform 4) | Phosphorylation | - | 25.58 | - | |
| 406 (in isoform 4) | Phosphorylation | - | 39.50 | - | |
| 428 | Phosphorylation | CQKKFARSDELVRHH HHHHHHCCHHHHHHH | 31.82 | - | |
| 433 | Phosphorylation | ARSDELVRHHNMHQR HCCHHHHHHHHHHHH | 37.66 | 9366517 | |
| 444 | Sumoylation | MHQRNMTKLQLAL-- HHHHHCCHHHHCC-- | 24.38 | 28112733 | |
| 461 | Phosphorylation | ------------------- ------------------- | 9366517 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 67 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
| 365 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
| 365 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
| 365 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
| 393 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
| 393 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
| 393 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of WT1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of WT1_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 136680 | Frasier syndrome (FS) | |||||
| 194070 | Wilms tumor 1 (WT1) | |||||
| 194080 | Denys-Drash syndrome (DDS) | |||||
| 256370 | Nephrotic syndrome 4 (NPHS4) | |||||
| 608978 | Meacham syndrome (MEACHS) | |||||
| Note=A chromosomal aberration involving WT1 may be a cause of desmoplastic small round cell tumor (DSRCT). Translocation t(11 | ||||||
| 22)(p13 | ||||||
| q12) with EWSR1. | ||||||
| 156240 | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Sumoylation | |
| Reference | PubMed |
| "SUMO-1 modification of the Wilms' tumor suppressor WT1."; Smolen G.A., Vassileva M.T., Wells J., Matunis M.J., Haber D.A.; Cancer Res. 64:7846-7851(2004). Cited for: SUBCELLULAR LOCATION, MUTAGENESIS OF LYS-73 AND LYS-177, ANDSUMOYLATION AT LYS-73 AND LYS-177. | |